Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2024-02-29 | 2024-05-16 | 220980 |
| TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2020-09-11 | 2020-12-17 | 124104 |
| TEVA-DONEPEZIL | 5MG | TABLET | Resolved | 2020-07-09 | 2021-04-21 | 119892 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120229 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2020-10-22 | 120232 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42629 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-12-17 | 2021-07-09 | 130301 |
| TEVA-DONEPEZIL | 5MG | TABLET | Actual shortage | 2025-01-30 | 2025-04-10 | 249207 |
| TEVA-DONEPEZIL | 10MG | TABLET | Actual shortage | 2025-03-06 | 2025-04-30 | 252084 |
| TEVA-DONEPEZIL | 5MG | TABLET | Resolved | 2024-03-21 | 2024-05-23 | 222941 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2017-08-01 | 2018-05-11 | 17878 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-08-17 | 2023-10-04 | 202249 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42632 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42635 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152414 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119898 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-10-08 | 2020-11-19 | 126032 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2024-03-07 | 2024-04-18 | 221543 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2024-09-05 | 2025-02-03 | 236805 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |